RARE Stock Summary and Trading Ideas (Ultragenyx Pharmaceutical | NASDAQ:RARE)

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

What symbol and exchange does Ultragenyx Pharmaceutical shares trade?

Ultragenyx Pharmaceutical trades on the NASDAQ stock market under the symbol RARE.

What is Ultragenyx Pharmaceutical stock price doing today?

As of December 31, 2025, RARE stock price climbed to $23.00 with 3,422,063 million shares trading.

What is Ultragenyx Pharmaceutical's Beta?

RARE has a beta of 1.02, meaning it tends to be more sensitive to market movements. RARE has a correlation of 0.12 to the broad based SPY ETF.

How much is Ultragenyx Pharmaceutical worth?

RARE has a market cap of $2.22 billion. This is considered a Mid Cap stock.

How much money does Ultragenyx Pharmaceutical make?

Last quarter Ultragenyx Pharmaceutical reported $160 million in Revenue and -$1.81 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.59.

What is the highest and lowest price Ultragenyx Pharmaceutical traded in the last 3 year period?

In the last 3 years, RARE traded as high as $60.37 and as low as $18.41.

What are the top ETFs holding Ultragenyx Pharmaceutical?

The top ETF exchange traded funds that RARE belongs to (by Net Assets): VTI, VB, XBI, VBK, VXF.

Is Ultragenyx Pharmaceutical (RARE) a good investment?

RARE has underperformed the market in the last year with a price return of -45.6% while the SPY ETF gained +17.2%. RARE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.5% and -33.0%, respectively, while the SPY returned +2.7% and +0.7%, respectively.

What are the support and resistance levels for Ultragenyx Pharmaceutical (RARE)?

RARE support price is $21.89 and resistance is $23.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RARE shares will trade within this expected range on the day.